[Interpretation of adrenergic vasoconstriction as an aspecific rejection factor of renal homotransplants].
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001808:Blood Vessels / Q000187:drug effects*; D004285:Dogs; D007668:Kidney / Q000098:blood supply*; D016030:Kidney Transplantation; D010643:Phenoxybenzamine / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology*; D011877:Radionuclide Imaging; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D014662:Vasoconstrictor Agents; D010643:Phenoxybenzamine; D010646:Phentolamine
Interpretazione della vasocostrizione adrenergica come fattore aspecifico di rigetto nell'omotrapianto renale.